T

Terveystalo Oyj
OMXH:TTALO

Watchlist Manager
Terveystalo Oyj
OMXH:TTALO
Watchlist
Price: 7.56 EUR -1.05% Market Closed
Market Cap: €960.4m

EV/EBIT

9.7
Current
54%
Cheaper
vs 3-y average of 20.9

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
9.7
=
Enterprise Value
€1.6B
/
EBIT
€141.4m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
9.7
=
Enterprise Value
€1.6B
/
EBIT
€141.4m

Valuation Scenarios

Terveystalo Oyj is trading below its 3-year average

If EV/EBIT returns to its 3-Year Average (20.9), the stock would be worth €16.38 (117% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+117%
Average Upside
104%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 9.7 €7.56
0%
3-Year Average 20.9 €16.38
+117%
5-Year Average 19.1 €14.96
+98%
Industry Average 20.7 €16.25
+115%
Country Average 17.9 €13.99
+85%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
€1.6B
/
Jan 2026
€141.4m
=
9.7
Current
€1.6B
/
Dec 2026
€161.5m
=
9.9
Forward
€1.6B
/
Dec 2027
€171.8m
=
9.3
Forward
€1.6B
/
Dec 2028
€173.7m
=
9.2
Forward
€1.6B
/
Dec 2029
€171.2m
=
9.3
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
FI
Terveystalo Oyj
OMXH:TTALO
967.6m EUR 9.7 10
US
CVS Health Corp
NYSE:CVS
99.6B USD 14.3 56.3
US
Cigna Group
XMUN:CGN
69.3B EUR 9.9 13.4
US
Cigna Corp
NYSE:CI
74.4B USD 0 12.5
DE
Fresenius Medical Care AG
XMUN:FME
22.8B EUR 16.6 23.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
22.7B EUR 13.7 18
US
Quest Diagnostics Inc
NYSE:DGX
21.8B USD 15.8 21.4
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD 17.2 24.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR 9.8 11.1
US
Guardant Health Inc
NASDAQ:GH
11.6B USD -27.6 -27.8
US
DaVita Inc
NYSE:DVA
10.3B USD 9.7 13.8

Market Distribution

Lower than 92% of companies in Finland
Percentile
8th
Based on 398 companies
8th percentile
9.7
Low
0.5 — 13.7
Typical Range
13.7 — 25.3
High
25.3 —
Distribution Statistics
Finland
Min 0.5
30th Percentile 13.7
Median 17.9
70th Percentile 25.3
Max 3 081.1

Terveystalo Oyj
Glance View

Market Cap
960.4m EUR
Industry
Health Care

Terveystalo Oyj, a leading figure in Finland's private healthcare sector, paints a comprehensive picture of modern healthcare services, effectively bridging the gap between medical expertise and patient-centered care. Established in 2001, the company operates a robust network of clinics and hospitals across Finland, addressing a broad spectrum of health needs from occupational health services to specialized medical treatments and diagnostics. By integrating cutting-edge technology and innovative healthcare solutions, Terveystalo ensures efficient service delivery and high-quality patient care. The company's strength lies in its expansive reach and diverse service offerings, which cater to both corporate clients and individual patients, thus cementing its role as a pillar of health and wellness in the Finnish market. Financially, Terveystalo generates revenue through a multi-faceted business model. The company offers occupational health services, which are a significant part of its income stream, as many Finnish companies utilize these services for their employees, ensuring workplace wellness and compliance with health regulations. Additionally, revenue flows from private consultations, medical procedures, and an array of diagnostic services. Terveystalo's investment in digital health tools, such as online consultations and telemedicine, further monetizes their operations by offering convenient access to healthcare, thereby broadening their customer base. This business strategy not only aligns with global trends towards digitalization but also positions Terveystalo as a resilient player in the face of evolving healthcare demands.

TTALO Intrinsic Value
14.8 EUR
Undervaluation 49%
Intrinsic Value
Price €7.56
T
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett